Is There a Drug Test for DMT and How Long Does It Stay?

Standard workplace and clinical drug tests do not screen for DMT. The substance is not included in the five-, ten-, or twelve-panel immunoassay tests used by most employers, courts, and treatment programs. DMT is also metabolized extraordinarily fast, with a blood half-life measured in minutes rather than hours, which makes even intentional detection difficult outside a very narrow window. Specialized laboratory techniques can identify DMT and its metabolites in blood, urine, and hair, but these are expensive, uncommon, and almost always reserved for forensic investigations or clinical research.

Why Standard Drug Panels Do Not Look for DMT

The drug screens you encounter at a job interview, a probation office, or an emergency room are immunoassay-based tests. They use antibodies designed to bind to specific drug classes: amphetamines, opioids, cannabis metabolites, benzodiazepines, cocaine, and sometimes a few others. DMT is a tryptamine, and tryptamines as a class are simply not among the analytes these panels target. No commercially available rapid test includes a DMT-specific antibody.

That said, the structural similarity between tryptamines and some amphetamine-class compounds can occasionally produce cross-reactivity on immunoassay screens. A study testing a range of designer drugs across five commercial immunoassay kits found that tryptamines were among the structural classes evaluated, and individual kits produced positive-hit rates ranging from about 19% to 57% depending on the kit and the drug class, though those rates reflected a broad mix of novel psychoactive substances at high concentrations rather than DMT specifically.¹ In practice, the chance that a single dose of smoked or injected DMT would trigger a false positive for amphetamines or ecstasy on a workplace screen is low, partly because the drug clears from your body so rapidly. But it is not zero, and anyone who used DMT very recently before a test that happens to use a broadly reactive kit could, in theory, get an unexpected flag.

How Fast DMT Leaves the Bloodstream

DMT disappears from blood faster than almost any other recreational psychoactive substance. In a clinical trial where healthy volunteers received DMT by intravenous infusion, the average elimination half-life was only about 9 to 12 minutes across different dose groups.² That means roughly half the drug is gone from your plasma within ten minutes of it entering your bloodstream, and the vast majority is cleared within an hour.

The reason for this speed is the enzyme monoamine oxidase A, which chews through DMT almost immediately after it reaches the liver. The primary breakdown product is indole-3-acetic acid, a compound that accounts for the overwhelming majority of recovered metabolites. When DMT is taken orally in something like ayahuasca, indole-3-acetic acid represented about 97% of recovered compounds, while a secondary metabolite, DMT-N-oxide, accounted for roughly 3%.³ In other words, your body converts DMT into something else almost as fast as it absorbs it.

A systematic review of DMT pharmacokinetics confirmed this pattern, noting that the fast elimination is driven primarily by MAO-A metabolism, with minor contributions from certain liver enzymes. The speed of this process is evident in how quickly the main metabolite peaks in plasma: after an intravenous dose, indole-3-acetic acid reaches its maximum concentration within about 20 to 37 minutes.⁴ For context, cannabis metabolites linger in your system for days or weeks. DMT’s active form is essentially gone from blood in under an hour.

Can DMT Be Found in Urine

Urine is the sample type used in the vast majority of drug testing, and it is a poor medium for catching DMT. Because the drug is so rapidly converted to indole-3-acetic acid, very little unmetabolized DMT makes it to the kidneys. A study comparing individuals with and without specific psychedelic experiences found that DMT was not detected in any urine specimen tested, underscoring how efficiently the body clears the parent compound.⁵

A specialized forensic lab using liquid chromatography-tandem mass spectrometry could, in principle, look for DMT metabolites in urine. A method developed specifically for forensic purposes was validated for detecting DMT and its metabolites, including indole-3-acetic acid and DMT-N-oxide, using LC-MS/MS.⁶ But there is a catch: indole-3-acetic acid is a naturally occurring compound in the human body (it is also a plant hormone), so merely finding it in urine does not prove DMT use. Testing would need to identify the parent drug or a more specific metabolite like DMT-N-oxide, and both are present at very low levels and for a very short time. Realistically, a urine sample collected more than a few hours after DMT use is unlikely to yield a positive result, even with the most sensitive equipment.

How Ayahuasca Changes the Timeline

The one major exception to DMT’s near-instant clearance involves ayahuasca, the Amazonian brew that combines DMT-containing plants with plants rich in harmala alkaloids. Those harmala alkaloids are potent inhibitors of monoamine oxidase A, the very enzyme responsible for destroying DMT. By temporarily blocking MAO-A, the brew allows DMT to survive the gut and liver long enough to reach the brain in psychoactive concentrations when taken orally.

This MAO inhibition also dramatically changes how long DMT persists in the body. Laboratory data show that when MAO-A is blocked, DMT’s intrinsic clearance drops by more than 90%, and its in-vitro half-life extends from about 34 minutes to over 370 minutes.² In a living person drinking ayahuasca, this means the drug stays in circulation substantially longer than it would from a smoked or injected dose. A method using gas chromatography and HPLC confirmed it was possible to characterize the pharmacokinetics of the four main ayahuasca alkaloids, including DMT, in human plasma after oral administration of the brew.⁷

The metabolite profile also shifts when the route changes. After oral ayahuasca, indole-3-acetic acid dominates overwhelmingly. But when DMT is smoked, bypassing the gut and first-pass liver metabolism, the picture looks different: unmetabolized DMT and DMT-N-oxide rise to about 10% and 28% of recovered compounds respectively, while indole-3-acetic acid drops to around 63%.³ This matters for detection because smoked DMT produces more of the non-IAA metabolites that are easier to distinguish from the body’s naturally occurring compounds, but it also clears faster because there is no MAO inhibitor prolonging its stay.

So if you are wondering about detection windows: smoked or injected DMT probably gives a window of detection in blood measured in minutes and in urine of perhaps a few hours at most. Ayahuasca extends that window, though precise numbers from controlled human studies are limited. An ayahuasca session could plausibly leave detectable traces in blood for several hours, and in urine for somewhat longer, depending on the dose and how sensitive the analytical method is.

Specialized Laboratory Methods That Can Find DMT

When researchers or forensic investigators specifically want to detect DMT, they turn to techniques that are far more powerful than immunoassay strips. The gold standard is liquid chromatography-tandem mass spectrometry, which can identify and quantify DMT and its metabolites at extremely low concentrations. A validated forensic method using this approach was designed to detect DMT alongside indole-3-acetic acid and DMT-N-oxide in biological samples.⁶ These methods can distinguish DMT from structurally similar tryptamines with high confidence, something immunoassays cannot do.

Another analytical approach uses ambient ionization high-resolution mass spectrometry, which has been applied to quantify DMT in ayahuasca brews themselves. Analysis of six different ayahuasca preparations found DMT concentrations ranging from about 46 to 231 milligrams per liter, with the plant source accounting for much of the variation.⁸ While that study focused on identifying the drug in the beverage rather than in a person’s body, the same high-resolution mass spectrometry principles apply to biological specimens. The practical barrier is access and cost: this equipment lives in forensic toxicology labs, research hospitals, and reference laboratories, not in your doctor’s office or a drug-testing clinic.

The situations where someone would actually order this kind of analysis are narrow. A coroner investigating a death involving suspected psychedelic use, a forensic toxicologist working a criminal case, or a clinical researcher monitoring participants in a DMT trial would use these tools. A pre-employment drug screen at a trucking company would not.

Hair Testing Offers a Much Longer Window

Hair analysis stands apart from blood and urine testing because it provides a record of drug exposure over weeks or months rather than hours. As hair grows, substances circulating in the bloodstream get incorporated into the hair shaft, creating a timeline of exposure that persists long after the drug has left the rest of the body.

For DMT, this has been demonstrated directly. A study analyzing hair samples from 28 known users of ayahuasca detected DMT at concentrations ranging from 3 to 1,109 picograms per milligram of hair, using a validated ultra-performance liquid chromatography-mass spectrometry method.⁹ That wide range reflects differences in dose, frequency of use, and individual variation in how much drug gets incorporated into the hair matrix. But the key takeaway is that hair testing can confirm DMT exposure months after the fact, long after any trace would have vanished from blood or urine.

Hair testing for DMT is still rare, though. It requires specialized equipment and a lab that knows to look for tryptamines. No standard hair-panel drug test includes DMT as an analyte. It would need to be specifically requested, and that typically happens only in forensic or legal contexts.

When Someone Else’s DMT Shows Up in Your Hair

One of the more striking findings in hair-testing research is that DMT can appear in the hair of people who never used the drug themselves. In a family law case, DMT was detected in the hair of the partner of a regular DMT smoker at concentrations between 4 and 13 picograms per milligram across multiple segments of hair. The concentrations increased from the root end toward the tip, suggesting cumulative environmental exposure over time. Even after aggressive decontamination procedures, the drug remained bound to the hair matrix.¹⁰

This has real implications. If hair testing for DMT were ever ordered in a custody dispute, a workplace investigation, or any legal proceeding, secondhand exposure from being around someone who smokes DMT could produce a positive result. The concentrations from environmental contamination tend to be much lower than those from personal use, and the pattern of distribution along the hair strand can help a forensic toxicologist distinguish between the two scenarios. But the fact that external contamination survives standard decontamination protocols means a positive hair test alone does not prove someone personally ingested the drug.

The Endogenous DMT Question

Your body actually produces small amounts of DMT on its own. The enzyme that synthesizes it has been identified in human tissues, and trace quantities of the compound have been measured in blood and cerebrospinal fluid. This raises a legitimate question: could naturally occurring DMT ever produce a positive test result?

In practice, no. Endogenous DMT exists at vanishingly small concentrations, far below the detection thresholds of even the most sensitive clinical assays used in drug testing. The amounts are so tiny that researchers studying endogenous DMT need to use specialized extraction and detection protocols just to confirm the compound is present at all. A study examining urine specimens specifically looking for endogenous psychedelics found that DMT was not detected in any sample, consistent with the compound being too rapidly metabolized and present in too low a quantity to show up through standard collection.⁵ You do not need to worry about your own body chemistry triggering a DMT-positive result.

What About 5-MeO-DMT and Other Tryptamines

DMT is one member of a larger family of tryptamine psychedelics, and people sometimes confuse the detection profiles of different compounds in this class. 5-MeO-DMT (found in certain toad secretions), psilocybin and psilocin (from mushrooms), and various synthetic tryptamines all share a core chemical structure but have different metabolic fates and different relationships to drug testing.

Psilocybin, for instance, is metabolized to psilocin, which can be detected in urine for roughly 24 hours with specialized testing. 5-MeO-DMT, like DMT, is rapidly broken down by MAO-A but follows a somewhat different metabolic pathway. None of these tryptamines appear on standard immunoassay panels. They share DMT’s fundamental problem from a testing perspective: they are cleared too quickly, are too structurally distinct from the major drug classes being screened, and require targeted analytical methods to identify.

The cross-reactivity study mentioned earlier tested tryptamines as a group alongside other novel psychoactive substance classes, and while some kits did flag certain compounds, the results were inconsistent across kits and not specific enough to identify which tryptamine was present.¹ If a screen did flag something, a confirmatory test using mass spectrometry would be needed to determine what compound was actually there. And at that point, the rapid clearance of these substances makes timing everything.

Variation Between Individuals

One thing that stands out in the clinical data is how much DMT pharmacokinetics vary from person to person. In the trial measuring blood levels after intravenous administration, peak DMT concentrations among subjects receiving the same dose ranged from 5 to 35 nanograms per milliliter at the lower dose, and from about 13 to 62 nanograms per milliliter at a moderately higher dose.² That is a roughly five-fold to seven-fold spread between individuals getting identical doses under controlled conditions. Half-life also varied, ranging from about 6 to 18 minutes across subjects.

This variability matters for detection because it means there is no single answer to “how long will DMT be detectable in my system.” Two people could smoke the same amount from the same batch, and one might clear it from blood in five minutes while the other takes closer to twenty. Differences in MAO-A activity, liver function, body composition, and genetics all contribute. Any detection window estimate is a rough average, not a guarantee.

Practical Takeaways for Specific Testing Scenarios

If you are facing a standard pre-employment drug screen (the kind that uses a urine cup and an immunoassay panel), DMT is extremely unlikely to be detected. These tests are not designed to find it, and even if you used DMT recently, the compound clears your body so quickly that the odds of a positive result are very low. The small possibility of cross-reactivity exists with some kits, but even then, a confirmatory test would be needed, and that confirmatory test would not find DMT.

If you are involved in a legal or forensic investigation where psychedelic use is specifically suspected, the picture changes. A forensic toxicology lab can detect DMT in blood if the sample is collected within a very short window after use, and in urine for perhaps a few hours. Hair analysis can confirm exposure weeks or months later, though it requires a laboratory that specifically tests for tryptamines. Ayahuasca use may be somewhat easier to detect than smoked DMT because the MAO-inhibitor component keeps the drug in circulation longer and because the harmala alkaloids themselves can be identified as co-markers.

For military, athletic, or other specialized testing programs that sometimes use broader analytical panels, the answer depends entirely on what analytes the specific program screens for. Some expanded panels used in forensic or post-mortem toxicology include tryptamines, but most clinical and occupational testing does not. If you are unsure what a specific panel includes, the testing laboratory’s published analyte list is the place to check, not general assumptions about what drug tests catch.